Shopping Cart 0
Cart Subtotal
USD 0

Global Market Insights on Needle-Free Drug Delivery Systems: Insights and Forecast, 2018-2025: Emphasis on Product (Prefilled needle-free injection systems, Prefilled needle-free injection systems); Technology (Jet Injectors, Transdermal Drug Delivery Systems, Inhaler Technology); Application (Insulin Delivery, Vaccination, Pediatric Injections, Pain Management); Injection Mode (Powder injections, Liquid injections, Liquid injections); Source of Power (Spring Loaded Jet Injector, Gas Powered Jet Injector, Battery Powered Jet Injector) and Region

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4850

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6790

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8850

Details

The report published" Global Needle Free Drug Delivery Device Market Insights to 2025 - provides a comprehensive analysis of needle free drug delivery device market at global level. The report focuses on overall market size for needle free drug delivery services by products (Fillable and prefilled needle-free injection systems), by various applications (Insulin Delivery, vaccinations, paediatric injections, pain management, by technology (jet injectors, transdermal drug delivery systems, inhaler technology), by injection method (powder injections, liquid injections and depot or projectile injection), by source of power (spring load jet injector systems, gas powdered jet injector and battery powdered jet injector system) by different regions such as North America, Europe, Asia Pacific, and Rest of world.

The report also provides a holistic view of the overall needle free drug delivery device market as well as regulations, growth drivers, restraints and factor analysis in terms of top investments undertaken, top product launches, major merger and acquisitions.

For an in-depth market overview, the report also includes a region wise analysis. For all the top industry players, a detailed product description, short- and long-term strategies, financials, SWOT analysis and recent developments are also included in the global needle free drug delivery device report. In addition to this, Porter 5s along with market share of leading needle free drug delivery device companies by application (Antares Pharma, Inc., Consort Medical, Crossject Soci�t� Anonyme, Inovio Pharmaceuticals, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M and PharmaJet) have also been covered.

Needle Free Drug Delivery Device Market Size

In terms of revenue, the needle free drug delivery device in has registered a remarkable growth with positive CAGR during the forecasted period. The needle free drug delivery device market has witnessed an overall rise in needle free penetration as well as needle free drug delivery devices adoption in last few years. Increasing number of chronic diseases incidence, inclination towards self-administration of drugs, growing technological advancements in the devices has driven the growth prospects of the market. In addition, rising demand for needle free drug delivery device system and stringent government regulations undertaken has also considerably catalysed the growth potential of the respective market.

Global Needle Free Drug Delivery Device Market Segmentation

Segmentation by Product

Needle free drug delivery device market fetched maximum revenues from prefilled needle free system on account of contamination free drug delivery by self-injection and popularity among the aging population. On the other hand, fillable system is expected to display overwhelming growth in years to come.

Segmentation by Technology

Jet injector needle free drug delivery device technology held dominant share in needle free drug delivery device market while the highest CAGR primarily was derived from transdermal drug delivery systems followed by inhaler technology in needle free drug delivery device to soaring demand for Jet injector needle free drug delivery device.

Segmentation by Application

Insulin needle free drug delivery market held the prime share in needle free technology market wherein pain management is the second lead share in the respective segment as it prevents the negative impacts of procedural pain and distress.

Segmentation by Injection Method

In respect to injection method, liquid injections held prominent share in needle free drug delivery market followed by Powder Injections market in needle free technology owing to predict the proportion of dose that is to be delivered into the human body.

Segmentation by Source of Power

Gas powdered jet injector technology held dominant share in needle free drug delivery market while the highest contribution in CAGR primarily was derived by spring load jet injector systems in needle free technology. The spring is released by triggering the barrel, leading to administration of jet stream of the drugs into subcutaneous, intramuscular or transdermal delivery of a drug.

Segmentation by Region

North America held the major share owing to high awareness regarding benefits of needle-free drug delivery devices, presence of developing healthcare facilities, and R&D expenditure by government. However, Asia-Pacific region is expected to witness the highest growth during the analysed period.

Scope of the report:

Global Needle Free Drug Delivery Device Market

Market Segmentation

Market Insights, by Products

Fillable needle-free injection systems

Prefilled needle-free injection systems

Market Insights, by Technology

Jet Injectors

Transdermal Drug Delivery Systems

Inhaler Technology

Market Insights, by Injection Method

Powder Injections

Liquid injections

Depot or Projectile Injection

Market Insights, by Applications

Insulin Delivery

Vaccinations

Paediatric Injections

Pain Management

Market Insights, by Source of Power

Spring Load Jet Injector Systems

Gas Powdered Jet Injector

Battery Powdered Jet Injector System

Company Profiles

Antares Pharma, Inc.

Consort Medical

Crossject Soci�t� Anonyme

Inovio Pharmaceuticals

Injex Pharma

Medical International Technology

Zosano Pharma

Valeritas

3M

PharmaJet

Reasons to buy:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers in depth analysis of prominent industry peers with primary focus on key business financials, product portfolio, expansion strategies and recent developments

Detailed examination on drivers, restraints, key trends and opportunities prevailing in the industry.

Examination of industry attractiveness with the help of Porter's Five Forces analysis

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Areas:

The Global Needle Free Drug Delivery Device Market can be customized to regional/country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customised solutions to clients.

 

 

 

READ MORE

Table Of Content

Scope

1. MARKET INTRODUCTION 12

1.1 Market Definition 12

1.2 Objective of the Study 12

1.3 Limitation 12

1.4 Stakeholders 13

1.5 Currency used in the Report 13

2. RESEARCH METHODOLOGY OR ASSUMPTION 14

2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14

2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15

3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16

3.1 General Overview 16

3.1.1 North America 16

3.1.2 Europe 17

4. INDUSTRY PERFORMANCE 18

5. EXECUTIVE SUMMARY 20

6. MARKET OVERVIEW 23

6.1 Introduction 23

6.2 Market Dynamics 24

6.2.1 Market Trend & Drivers 24

6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24

6.2.3 Inclination Towards Self Administration of Drugs 26

6.2.4 Growing Technological Advancements in the Devices 27

6.3 Market Challenges 27

6.3.1 Ambiguity in the Specifications of Needle Free Devices 27

6.3.2 Limitations associated with Micro Needle Patches 28

6.4 Market Opportunities 28

6.4.1 Increase in the number of start-ups and Investments 28

6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30

7. KEY MARKET INDICATORS 31

7.1 General Overview 31

7.1.1 Demand and Supply Side Analysis 31

7.1.1.1 Top Winning Strategies 32

7.1.1.1.1 Top Product launches 32

7.1.1.1.2 Top Business Expansions & Investments 33

7.1.1.1.3 Top Acquisition and Collaborations 34

7.1.2 Needle-free injection technology manufacturing process value chain 35

8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37

8.1 General Overview 37

8.1.1 Prefilled needle-free injection systems 38

8.1.2 Fillable needle-free injection systems 39

9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41

9.1 General Overview 41

9.1.1 Jet Injectors 42

9.1.2 Transdermal Drug Delivery Systems 43

9.1.3 Inhaler Technology 44

10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46

10.1 General Overview 46

10.1.1 Insulin Delivery 47

10.1.2 Vaccination 48

10.1.3 Pediatric Injections 49

10.1.4 Pain Management 50

11. MARKET INSIGHTS BY INJECTION METHODS 51

11.1 General Overview 51

11.1.1 Powder injections 52

11.1.2 Liquid injections 53

11.1.3 Depot or Projectile Injection 54

12. MARKET INSIGHTS BY SOURCE POWER 55

12.1 General Overview 55

12.1.1 Spring Loaded Jet Injector 56

12.1.2 Gas Powered Jet Injector 57

12.1.3 Battery Powered Jet Injector 58

13. MARKET INSIGHTS BY REGION 59

13.1 General Overview 59

13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60

13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62

13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62

13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63

13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63

13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64

13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64

13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68

13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68

13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69

13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69

13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70

13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70

13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74

13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74

13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75

13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75

13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76

13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76

13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78

13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78

13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79

13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79

13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80

14. COMPETITIVE SCENARIO 81

14.1 Porter's Five forces analysis 81

14.1.1 Bargaining power of Buyer 81

14.1.2 Bargaining power of Supplier 82

14.1.3 The threat of new entrants 82

14.1.4 Availability of Substitute 83

14.1.5 Industry Rivalry 83

14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84

15. COMPANY PROFILES 85

15.1 Antares Pharma, Inc. 85

15.1.1 Key Facts 85

15.1.2 Business Description 85

15.1.3 Key Product/Services Offerings 86

15.1.4 SWOT Analysis 87

15.1.5 Key Financials 87

15.1.6 Revenue Split 88

15.1.7 Recent Developments 88

15.1.8 Funding 89

15.2 Consort Medical 90

15.2.1 Key Facts 90

15.2.2 Business Description 90

15.2.3 Key Product/Services Offerings 91

15.2.4 SWOT Analysis 92

15.2.5 Key Financials 92

15.2.6 Revenue Split 93

15.2.7 Recent Developments 93

15.3 Crossject Societe Anonyme 94

15.3.1 Key Facts 94

15.3.2 Business Description 94

15.3.3 SWOT Analysis 95

15.3.4 Key Financials 95

15.3.5 Revenue Split 96

15.3.6 Recent Developments 96

15.3.7 Funding 96

15.4 Inovio Pharmaceuticals 97

15.4.1 Key Facts 97

15.4.2 Business Description 97

15.4.3 SWOT Analysis 99

15.4.4 Key Financials 100

15.4.5 Revenue Split 100

15.4.6 Recent Developments 101

15.4.7 Funding 101

15.5 Injex Pharma 102

15.5.1 Key Facts 102

15.5.2 Business Description 102

15.5.3 Key Product/Services Offerings 102

15.5.4 SWOT Analysis 103

15.6 Medical International Technology 104

15.6.1 Key Facts 104

15.6.2 Business Description 104

15.6.3 Key Product/Services Offerings 105

15.6.4 SWOT Analysis 105

15.6.5 Key Financials 106

15.6.6 Revenue Split 106

15.6.7 Recent Developments 106

15.7 Zosano Pharma 107

15.7.1 Key Facts 107

15.7.2 Business Description 107

15.7.3 Key Product/Services Offerings 108

15.7.4 SWOT Analysis 108

15.7.5 Key Financials 109

15.7.6 Revenue Split 109

15.7.7 Recent Developments 110

15.8 Valeritas 111

15.8.1 Key Facts 111

15.8.2 Business Description 111

15.8.3 Key Product/Services Offerings 112

15.8.4 SWOT Analysis 112

15.8.5 Recent Developments 113

15.8.6 Funding 113

15.9 3M 114

15.9.1 Key Facts 114

15.9.2 Business Description 114

15.9.3 Key Product/Services Offerings 115

15.9.4 SWOT Analysis 116

15.9.5 Key Financials 116

15.9.6 Revenue Split 117

15.9.7 Recent Developments 117

15.9.8 Funding 117

15.10 PharmaJet 118

15.10.1 Key Facts 118

15.10.2 Business Description 118

15.10.3 Key Product/Services Offerings 118

15.10.4 SWOT Analysis 119

15.10.5 Recent Developments 120

15.10.6 Funding 120


List Of Figure

FIG. 1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14

FIG. 2 Global Countries with most Adults Living with Diabetes, 2017 20

FIG. 3 Global Needle Free Drug Delivery Device Market 2018-2025 (USD Billion) 21

FIG. 4 Facts about Chronic Disease in the US, 2016 25

FIG. 5 Frequency of Needle Stick Injuries, by Devices 25

FIG. 6 Process for Self-Administration of Medicines (SAMS) 26

FIG. 7 Global Top Country, by Start-Up County 2017 29

FIG. 8 Global Funding, by Region 2016 & 2017 (USD billion) 29

FIG. 9 Health Expenditure Per Capita in Asia-Pacific, by Country 2015 (USD PPP) 30

FIG. 10 Needle-free Injection Technology Manufacturing Process 35

FIG. 11 Global Needle-Free Drug Delivery Device Market Share, by Product Type, 2017 & 2025 (%) 37

FIG. 12 Global Needle-Free Drug Delivery Device Market, by Product 2018-25 (USD Billion) 37

FIG. 13 Global Needle-Free Drug Delivery Device Market Share by Technology, 2017 & 2025 (%) 41

FIG. 14 Global Needle-Free Drug Delivery Device Market, by Technology, 2018-25 (USD Billion) 41

FIG. 15 Global Needle-Free Drug Delivery Device Market Share, by Application, 2017 & 2025 (%) 46

FIG. 16 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 46

FIG. 17 Global Needle-Free Drug Delivery Device Market Share by Injection Method, 2017 & 2025 (%) 51

FIG. 18 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 51

FIG. 19 Global Needle-Free Drug Delivery Device Market Share by Source Power, 2017 & 2025 (%) 55

FIG. 20 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 55

FIG. 21 Global Needle-Free Drug Delivery Device Market Share by Region, 2017 & 2025 (%) 59

FIG. 22 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 59

FIG. 23 Y-o-Y Growth rate of US Healthcare Expenditure (2011-2016), % 60

FIG. 24 Number and % of U.S. Population with Diagnosed Diabetes (2006-2015) 61

FIG. 25 Estimated age-adjusted prevalence of diagnosed diabetes by race/ethnicity and sex among adults aged ?18 US, 2013-2015 61

FIG. 26 Europe % of population over 65 years old, by Country 2017 65

FIG. 27 Number of people with diabetes in EU28, 2000 and 2017 65

FIG. 28 Europe % of Adult population with Diabetes, by Country 2017 66

FIG. 29 Estimated Incidence rate for all Cancers in Europe, by country, 2018 67

FIG. 30 HIV Prevalence in Asia-Pacific % of Population, by Country 2017 72

FIG. 31 Asia-Pacific Medical Equipment Market USD Billion (2015-2018) 72

FIG. 32 Ratio of people aged 15-64 to people aged over 65 years in Asia-Pacific, 2015 and 2050 73

FIG. 33 Porter's Five forces analysis of Global Needle-Free Drug Delivery Device 81

FIG. 34 Patent count of Smart Drug Delivery System 84

FIG. 35 Antares Pharma Inc. SWOT Analysis 87

FIG. 36 Antares Pharma Inc. Revenue Split, 2018 88

FIG. 37 Consort Medical SWOT Analysis 92

FIG. 38 Consort Medical Revenue Split, 2017 93

FIG. 39 Crossject Societe Anonyme SWOT Analysis 95

FIG. 40 Crossject Societe Anonyme Revenue Split, 2017 96

FIG. 41 Inovio Pharmaceuticals SWOT Analysis 99

FIG. 42 Inovio Pharmaceuticals Revenue Split, 2017 100

FIG. 43 Injex Pharma, SWOT Analysis 103

FIG. 44 Medical International Technology, SWOT Analysis 105

FIG. 45 Medical International Technology Revenue Split, 2018 106

FIG. 46 Zosano Pharma SWOT Analysis 108

FIG. 47 Zosano Pharma Revenue Split, 2017 109

FIG. 48 Valeritas, SWOT Analysis 112

FIG. 49 3M SWOT Analysis 116

FIG. 50 3M Revenue Split, 2017 117

FIG. 51 Medtronic Plc SWOT Analysis 119


List Of Table

TABLE 1 Global Needle Free Drug Delivery Device Market by Region, 2018-25 (USD Billion) 22

TABLE 2 Examples of Prefilled Needle Free Devices 27

TABLE 3 Examples of Prefilled Needle-Free Devices 38

TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (USD Billion) 39

TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (USD Billion) 39

TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (USD Billion) 42

TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (USD Billion) 43

TABLE 8 Global Inhaler Technology by Region, 2018-25 (USD Billion) 44

TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (USD Billion) 47

TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (USD Billion) 48

TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (USD Billion) 49

TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (USD Billion) 50

TABLE 13 Specification of Needle-Free Devices By Injection Methods 52

TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (USD Billion) 53

TABLE 15 Examples of Drugs Administered via Liquid Jet Injector 53

TABLE 16 Global Needle-Free Liquid Injection Market by Region, 2018-25 (USD Billion) 54

TABLE 17 Global Needle-Free Depot or Projectile Injection Market by Region, 2018-25 (USD Billion) 54

TABLE 18 Global Needle-Free Spring Loaded Jet Injector Market by Region, 2018-25 (USD Billion) 56

TABLE 19 Global Needle-Free Gas Powered Jet Injector Market by Region, 2018-25 (USD Billion) 57

TABLE 20 Global Needle-Free Battery Powered Jet Injector Market by Region, 2018-25 (USD Billion) 58

TABLE 21 North America Needle Free Drug Delivery Device by Product 2018-25 (USD Billion) 62

TABLE 22 North America Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 62

TABLE 23 North America Needle-Free Drug Delivery Device by Application,2018-2025 (USD Billion) 63

TABLE 24 North America Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 63

TABLE 25 North America Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (USD Billion) 64

TABLE 26 Europe Needle-Free Drug Delivery Device by Product, 2018-25 (USD Billion) 68

TABLE 27 Europe Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 68

TABLE 28 Europe Needle-Free Drug Delivery Device by Application,2018-2025 (USD Billion) 69

TABLE 29 Europe Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 69

TABLE 30 Europe Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (USD Billion) 70

TABLE 31 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in Asia-Pacific 71

TABLE 32 Asia Pacific Needle-Free Drug Delivery Device by Product, 2018-25 (USD Billion) 74

TABLE 33 Asia Pacific Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 74

TABLE 34 Asia Pacific Needle-Free Drug Delivery Device by Application, 2018-2025 (USD Billion) 75

TABLE 35 Asia Pacific Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 75

TABLE 36 Asia Pacific Needle-Free Drug Delivery Device by Source of Power, 2018-25 (USD Billion) 76

TABLE 37 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in RoW 77

TABLE 38 RoW Needle-Free Drug Delivery Device Market by Product, 2018-25 (USD Billion) 78

TABLE 39 RoW Needle-Free Drug Delivery Device Market by Technology, 2018-25 (USD Billion) 78

TABLE 40 RoW Needle-Free Drug Delivery Device Market by Application,2018-2025 (USD Billion) 79

TABLE 41 RoW Needle-Free Drug Delivery Device Market by Injection Method, 2018-25 (USD Billion) 79

TABLE 42 RoW Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (USD Billion) 80

TABLE 43 Antares Pharma Inc. Key Facts 85

TABLE 44 Product segmentation of Antares Pharma Inc. 86

TABLE 45 Antares Pharma, Inc. Growth Strategy 86

TABLE 46 Antares Pharma Inc. Financials US USD Million 87

TABLE 47 Consort Medical Key Facts 90

TABLE 48 Product segmentation of Consort Medical 91

TABLE 49 Consort Medical Growth Strategy 91

TABLE 50 Consort Medical Financials, USD Million 92

TABLE 51 Crossject Societe Key Facts 94

TABLE 52 Product segmentation of Crossject Societe Anonyme 94

TABLE 53 Crossject Societe Anonyme Growth Strategy 95

TABLE 54 Crossject Societe Anonyme Financials, USD Million 95

TABLE 55 Inovio Pharmaceutical Key Facts 97

TABLE 56 Product segmentation of Inovio Pharmaceuticals 98

TABLE 57 Inovio Pharmaceuticals Growth Strategy 99

TABLE 58 Inovio Pharmaceuticals Financials, USD Million 100

TABLE 59 Injex Pharma Key Facts 102

TABLE 60 Product segmentation of Injex Pharma 102

TABLE 61 Injex Pharma Growth Strategy 103

TABLE 62 Medical International Technology Key Facts 104

TABLE 63 Product segmentation of Medical International Technology 105

TABLE 64 Medical International Technology Growth Strategy 105

TABLE 65 Medical International Technology Financials, USD Million 106

TABLE 66 Zosano Pharma Key Facts 107

TABLE 67 Product segmentation of Zosano Pharma 108

TABLE 68 Zosano Pharma Growth Strategy 108

TABLE 69 Zosano Pharma Financials, USD Million 109

TABLE 70 Valeritas Key Facts 111

TABLE 71 Product segmentation of Valeritas 112

TABLE 72 Valeritas Growth Strategy 112

TABLE 73 3M Key Facts 114

TABLE 74 Product segmentation of 3M 115

TABLE 75 3M Growth Strategy 115

TABLE 76 3M Financials, USD Million 116

TABLE 77 PharmaJet Key Facts 118

TABLE 78 Product segmentation of PharmaJet 118

TABLE 79 Pharmajet Growth Strategy 11

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Antares Pharma, Inc., Consort Medical, Crossject Societe Anonyme, Crossject Societe Anonyme, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M, PharmaJet

Company Profile

Company Profile Title

The report published" Global Needle Free Drug Delivery Device Market Insights to 2025 - provides a comprehensive analysis of needle free drug delivery device market at global level. The report focuses on overall market size for needle free drug delivery services by products (Fillable and prefilled needle-free injection systems), by various applications (Insulin Delivery, vaccinations, paediatric injections, pain management, by technology (jet injectors, transdermal drug delivery systems, inhaler technology), by injection method (powder injections, liquid injections and depot or projectile injection), by source of power (spring load jet injector systems, gas powdered jet injector and battery powdered jet injector system) by different regions such as North America, Europe, Asia Pacific, and Rest of world.

The report also provides a holistic view of the overall needle free drug delivery device market as well as regulations, growth drivers, restraints and factor analysis in terms of top investments undertaken, top product launches, major merger and acquisitions.

For an in-depth market overview, the report also includes a region wise analysis. For all the top industry players, a detailed product description, short- and long-term strategies, financials, SWOT analysis and recent developments are also included in the global needle free drug delivery device report. In addition to this, Porter 5s along with market share of leading needle free drug delivery device companies by application (Antares Pharma, Inc., Consort Medical, Crossject Soci�t� Anonyme, Inovio Pharmaceuticals, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M and PharmaJet) have also been covered.

Needle Free Drug Delivery Device Market Size

In terms of revenue, the needle free drug delivery device in has registered a remarkable growth with positive CAGR during the forecasted period. The needle free drug delivery device market has witnessed an overall rise in needle free penetration as well as needle free drug delivery devices adoption in last few years. Increasing number of chronic diseases incidence, inclination towards self-administration of drugs, growing technological advancements in the devices has driven the growth prospects of the market. In addition, rising demand for needle free drug delivery device system and stringent government regulations undertaken has also considerably catalysed the growth potential of the respective market.

Global Needle Free Drug Delivery Device Market Segmentation

Segmentation by Product

Needle free drug delivery device market fetched maximum revenues from prefilled needle free system on account of contamination free drug delivery by self-injection and popularity among the aging population. On the other hand, fillable system is expected to display overwhelming growth in years to come.

Segmentation by Technology

Jet injector needle free drug delivery device technology held dominant share in needle free drug delivery device market while the highest CAGR primarily was derived from transdermal drug delivery systems followed by inhaler technology in needle free drug delivery device to soaring demand for Jet injector needle free drug delivery device.

Segmentation by Application

Insulin needle free drug delivery market held the prime share in needle free technology market wherein pain management is the second lead share in the respective segment as it prevents the negative impacts of procedural pain and distress.

Segmentation by Injection Method

In respect to injection method, liquid injections held prominent share in needle free drug delivery market followed by Powder Injections market in needle free technology owing to predict the proportion of dose that is to be delivered into the human body.

Segmentation by Source of Power

Gas powdered jet injector technology held dominant share in needle free drug delivery market while the highest contribution in CAGR primarily was derived by spring load jet injector systems in needle free technology. The spring is released by triggering the barrel, leading to administration of jet stream of the drugs into subcutaneous, intramuscular or transdermal delivery of a drug.

Segmentation by Region

North America held the major share owing to high awareness regarding benefits of needle-free drug delivery devices, presence of developing healthcare facilities, and R&D expenditure by government. However, Asia-Pacific region is expected to witness the highest growth during the analysed period.

Scope of the report:

Global Needle Free Drug Delivery Device Market

Market Segmentation

Market Insights, by Products

Fillable needle-free injection systems

Prefilled needle-free injection systems

Market Insights, by Technology

Jet Injectors

Transdermal Drug Delivery Systems

Inhaler Technology

Market Insights, by Injection Method

Powder Injections

Liquid injections

Depot or Projectile Injection

Market Insights, by Applications

Insulin Delivery

Vaccinations

Paediatric Injections

Pain Management

Market Insights, by Source of Power

Spring Load Jet Injector Systems

Gas Powdered Jet Injector

Battery Powdered Jet Injector System

Company Profiles

Antares Pharma, Inc.

Consort Medical

Crossject Soci�t� Anonyme

Inovio Pharmaceuticals

Injex Pharma

Medical International Technology

Zosano Pharma

Valeritas

3M

PharmaJet

Reasons to buy:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers in depth analysis of prominent industry peers with primary focus on key business financials, product portfolio, expansion strategies and recent developments

Detailed examination on drivers, restraints, key trends and opportunities prevailing in the industry.

Examination of industry attractiveness with the help of Porter's Five Forces analysis

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Areas:

The Global Needle Free Drug Delivery Device Market can be customized to regional/country level or any other market segment. Besides this, UMI understands that you may have your own business need, hence we also provide fully customised solutions to clients.

 

 

 

READ MORE

Scope

1. MARKET INTRODUCTION 12

1.1 Market Definition 12

1.2 Objective of the Study 12

1.3 Limitation 12

1.4 Stakeholders 13

1.5 Currency used in the Report 13

2. RESEARCH METHODOLOGY OR ASSUMPTION 14

2.1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14

2.1.1 Main objective of the Needle Free Drug Delivery Devices Market Study 15

3. REGULATORY FRAMEWORK AND KEY DEVELOPMENT 16

3.1 General Overview 16

3.1.1 North America 16

3.1.2 Europe 17

4. INDUSTRY PERFORMANCE 18

5. EXECUTIVE SUMMARY 20

6. MARKET OVERVIEW 23

6.1 Introduction 23

6.2 Market Dynamics 24

6.2.1 Market Trend & Drivers 24

6.2.2 Rising Prevalence of Chronic and Lifestyle Diseases 24

6.2.3 Inclination Towards Self Administration of Drugs 26

6.2.4 Growing Technological Advancements in the Devices 27

6.3 Market Challenges 27

6.3.1 Ambiguity in the Specifications of Needle Free Devices 27

6.3.2 Limitations associated with Micro Needle Patches 28

6.4 Market Opportunities 28

6.4.1 Increase in the number of start-ups and Investments 28

6.4.2 Growing Adoption in Emerging Countries of Asia-Pacific Region 30

7. KEY MARKET INDICATORS 31

7.1 General Overview 31

7.1.1 Demand and Supply Side Analysis 31

7.1.1.1 Top Winning Strategies 32

7.1.1.1.1 Top Product launches 32

7.1.1.1.2 Top Business Expansions & Investments 33

7.1.1.1.3 Top Acquisition and Collaborations 34

7.1.2 Needle-free injection technology manufacturing process value chain 35

8. MARKET INSIGHTS BY PRODUCT TYPE (2018-25) 37

8.1 General Overview 37

8.1.1 Prefilled needle-free injection systems 38

8.1.2 Fillable needle-free injection systems 39

9. MARKET INSIGHTS BY TECHNOLOGY (2018-25) 41

9.1 General Overview 41

9.1.1 Jet Injectors 42

9.1.2 Transdermal Drug Delivery Systems 43

9.1.3 Inhaler Technology 44

10. MARKET INSIGHTS BY APPLICATION TYPE (2018- 2025) 46

10.1 General Overview 46

10.1.1 Insulin Delivery 47

10.1.2 Vaccination 48

10.1.3 Pediatric Injections 49

10.1.4 Pain Management 50

11. MARKET INSIGHTS BY INJECTION METHODS 51

11.1 General Overview 51

11.1.1 Powder injections 52

11.1.2 Liquid injections 53

11.1.3 Depot or Projectile Injection 54

12. MARKET INSIGHTS BY SOURCE POWER 55

12.1 General Overview 55

12.1.1 Spring Loaded Jet Injector 56

12.1.2 Gas Powered Jet Injector 57

12.1.3 Battery Powered Jet Injector 58

13. MARKET INSIGHTS BY REGION 59

13.1 General Overview 59

13.1.1 North America Needle-Free Drug Delivery Market (2018-2025) 60

13.1.1.1 North America Needle Free Drug Delivery Market, by Product 62

13.1.1.2 North America Needle-Free Drug Delivery Market, by Technology 62

13.1.1.3 North America Needle-Free Drug Delivery Device Market, by Application 63

13.1.1.4 North America Needle-Free Drug Delivery Market, by Injection Method 63

13.1.1.5 North America Needle Free Drug Delivery Device Market by, Source of Power 64

13.1.2 Europe Needle-Free Drug Delivery Device Market (2018-2025) 64

13.1.2.1 Europe Needle-Free Drug Delivery Device Market, by Product 68

13.1.2.2 Europe Needle-Free Drug Delivery Device Market, by Technology 68

13.1.2.3 Europe Needle-Free Drug Delivery Device Market, by Application 69

13.1.2.4 Europe Needle Free Drug Delivery Device Market, by Injection Method 69

13.1.2.5 Europe Needle-Free Drug Delivery Device Market, by Source of Power 70

13.1.3 Asia Pacific Needle-Free Drug Delivery Device Market (2018-2025) 70

13.1.3.1 Asia Pacific Needle-Free Drug Delivery Device Market, by Product 74

13.1.3.2 Asia Pacific Needle-Free Drug Delivery Device Market, by Technology 74

13.1.3.3 Asia Pacific Needle Free Drug Delivery Device Market, by Application 75

13.1.3.4 Asia Pacific Needle-Free Drug Delivery Device Market, by Injection Method 75

13.1.3.5 Asia Pacific Needle-Free Drug Delivery Device Market, by Source of Power 76

13.1.4 Rest of World Needle-Free Drug Delivery Device Market (2018-2025) 76

13.1.4.1 RoW Needle-Free Drug Delivery Device Market, by Product 78

13.1.4.2 RoW Needle-Free Drug Delivery Device Market, by Technology 78

13.1.4.3 RoW Needle-Free Drug Delivery Device Market, by Application 79

13.1.4.4 RoW Needle Free Needle-Free Device Market, by Injection Method 79

13.1.4.5 RoW Needle-Free Drug Delivery Device Market by Source of Power 80

14. COMPETITIVE SCENARIO 81

14.1 Porter's Five forces analysis 81

14.1.1 Bargaining power of Buyer 81

14.1.2 Bargaining power of Supplier 82

14.1.3 The threat of new entrants 82

14.1.4 Availability of Substitute 83

14.1.5 Industry Rivalry 83

14.2 Global Needle-Free Drug Delivery Market Share Analysis, 2017 84

15. COMPANY PROFILES 85

15.1 Antares Pharma, Inc. 85

15.1.1 Key Facts 85

15.1.2 Business Description 85

15.1.3 Key Product/Services Offerings 86

15.1.4 SWOT Analysis 87

15.1.5 Key Financials 87

15.1.6 Revenue Split 88

15.1.7 Recent Developments 88

15.1.8 Funding 89

15.2 Consort Medical 90

15.2.1 Key Facts 90

15.2.2 Business Description 90

15.2.3 Key Product/Services Offerings 91

15.2.4 SWOT Analysis 92

15.2.5 Key Financials 92

15.2.6 Revenue Split 93

15.2.7 Recent Developments 93

15.3 Crossject Societe Anonyme 94

15.3.1 Key Facts 94

15.3.2 Business Description 94

15.3.3 SWOT Analysis 95

15.3.4 Key Financials 95

15.3.5 Revenue Split 96

15.3.6 Recent Developments 96

15.3.7 Funding 96

15.4 Inovio Pharmaceuticals 97

15.4.1 Key Facts 97

15.4.2 Business Description 97

15.4.3 SWOT Analysis 99

15.4.4 Key Financials 100

15.4.5 Revenue Split 100

15.4.6 Recent Developments 101

15.4.7 Funding 101

15.5 Injex Pharma 102

15.5.1 Key Facts 102

15.5.2 Business Description 102

15.5.3 Key Product/Services Offerings 102

15.5.4 SWOT Analysis 103

15.6 Medical International Technology 104

15.6.1 Key Facts 104

15.6.2 Business Description 104

15.6.3 Key Product/Services Offerings 105

15.6.4 SWOT Analysis 105

15.6.5 Key Financials 106

15.6.6 Revenue Split 106

15.6.7 Recent Developments 106

15.7 Zosano Pharma 107

15.7.1 Key Facts 107

15.7.2 Business Description 107

15.7.3 Key Product/Services Offerings 108

15.7.4 SWOT Analysis 108

15.7.5 Key Financials 109

15.7.6 Revenue Split 109

15.7.7 Recent Developments 110

15.8 Valeritas 111

15.8.1 Key Facts 111

15.8.2 Business Description 111

15.8.3 Key Product/Services Offerings 112

15.8.4 SWOT Analysis 112

15.8.5 Recent Developments 113

15.8.6 Funding 113

15.9 3M 114

15.9.1 Key Facts 114

15.9.2 Business Description 114

15.9.3 Key Product/Services Offerings 115

15.9.4 SWOT Analysis 116

15.9.5 Key Financials 116

15.9.6 Revenue Split 117

15.9.7 Recent Developments 117

15.9.8 Funding 117

15.10 PharmaJet 118

15.10.1 Key Facts 118

15.10.2 Business Description 118

15.10.3 Key Product/Services Offerings 118

15.10.4 SWOT Analysis 119

15.10.5 Recent Developments 120

15.10.6 Funding 120


List Of Figure

FIG. 1 Research Methodology for Global Needle Free Drug Delivery Devices Market 14

FIG. 2 Global Countries with most Adults Living with Diabetes, 2017 20

FIG. 3 Global Needle Free Drug Delivery Device Market 2018-2025 (USD Billion) 21

FIG. 4 Facts about Chronic Disease in the US, 2016 25

FIG. 5 Frequency of Needle Stick Injuries, by Devices 25

FIG. 6 Process for Self-Administration of Medicines (SAMS) 26

FIG. 7 Global Top Country, by Start-Up County 2017 29

FIG. 8 Global Funding, by Region 2016 & 2017 (USD billion) 29

FIG. 9 Health Expenditure Per Capita in Asia-Pacific, by Country 2015 (USD PPP) 30

FIG. 10 Needle-free Injection Technology Manufacturing Process 35

FIG. 11 Global Needle-Free Drug Delivery Device Market Share, by Product Type, 2017 & 2025 (%) 37

FIG. 12 Global Needle-Free Drug Delivery Device Market, by Product 2018-25 (USD Billion) 37

FIG. 13 Global Needle-Free Drug Delivery Device Market Share by Technology, 2017 & 2025 (%) 41

FIG. 14 Global Needle-Free Drug Delivery Device Market, by Technology, 2018-25 (USD Billion) 41

FIG. 15 Global Needle-Free Drug Delivery Device Market Share, by Application, 2017 & 2025 (%) 46

FIG. 16 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 46

FIG. 17 Global Needle-Free Drug Delivery Device Market Share by Injection Method, 2017 & 2025 (%) 51

FIG. 18 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 51

FIG. 19 Global Needle-Free Drug Delivery Device Market Share by Source Power, 2017 & 2025 (%) 55

FIG. 20 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 55

FIG. 21 Global Needle-Free Drug Delivery Device Market Share by Region, 2017 & 2025 (%) 59

FIG. 22 Global Needle-Free Drug Delivery Device Market by Application, 2018-25 (USD Billion) 59

FIG. 23 Y-o-Y Growth rate of US Healthcare Expenditure (2011-2016), % 60

FIG. 24 Number and % of U.S. Population with Diagnosed Diabetes (2006-2015) 61

FIG. 25 Estimated age-adjusted prevalence of diagnosed diabetes by race/ethnicity and sex among adults aged ?18 US, 2013-2015 61

FIG. 26 Europe % of population over 65 years old, by Country 2017 65

FIG. 27 Number of people with diabetes in EU28, 2000 and 2017 65

FIG. 28 Europe % of Adult population with Diabetes, by Country 2017 66

FIG. 29 Estimated Incidence rate for all Cancers in Europe, by country, 2018 67

FIG. 30 HIV Prevalence in Asia-Pacific % of Population, by Country 2017 72

FIG. 31 Asia-Pacific Medical Equipment Market USD Billion (2015-2018) 72

FIG. 32 Ratio of people aged 15-64 to people aged over 65 years in Asia-Pacific, 2015 and 2050 73

FIG. 33 Porter's Five forces analysis of Global Needle-Free Drug Delivery Device 81

FIG. 34 Patent count of Smart Drug Delivery System 84

FIG. 35 Antares Pharma Inc. SWOT Analysis 87

FIG. 36 Antares Pharma Inc. Revenue Split, 2018 88

FIG. 37 Consort Medical SWOT Analysis 92

FIG. 38 Consort Medical Revenue Split, 2017 93

FIG. 39 Crossject Societe Anonyme SWOT Analysis 95

FIG. 40 Crossject Societe Anonyme Revenue Split, 2017 96

FIG. 41 Inovio Pharmaceuticals SWOT Analysis 99

FIG. 42 Inovio Pharmaceuticals Revenue Split, 2017 100

FIG. 43 Injex Pharma, SWOT Analysis 103

FIG. 44 Medical International Technology, SWOT Analysis 105

FIG. 45 Medical International Technology Revenue Split, 2018 106

FIG. 46 Zosano Pharma SWOT Analysis 108

FIG. 47 Zosano Pharma Revenue Split, 2017 109

FIG. 48 Valeritas, SWOT Analysis 112

FIG. 49 3M SWOT Analysis 116

FIG. 50 3M Revenue Split, 2017 117

FIG. 51 Medtronic Plc SWOT Analysis 119


List Of Table

TABLE 1 Global Needle Free Drug Delivery Device Market by Region, 2018-25 (USD Billion) 22

TABLE 2 Examples of Prefilled Needle Free Devices 27

TABLE 3 Examples of Prefilled Needle-Free Devices 38

TABLE 4 Global Prefilled Needle-Free Injection System by Region, 2018-25 (USD Billion) 39

TABLE 5 Global Fillable Needle Free Injection System by Region, 2018-25 (USD Billion) 39

TABLE 6 Global Jet Injector Market Size by Region, 2018-25 (USD Billion) 42

TABLE 7 Global Transdermal Drug Delivery Systems, by Region, 2018-25 (USD Billion) 43

TABLE 8 Global Inhaler Technology by Region, 2018-25 (USD Billion) 44

TABLE 9 Global Needle-Free Insulin Delivery Market by Region, 2018-25 (USD Billion) 47

TABLE 10 Global Needle-Free Vaccination Market by Region, 2018-25 (USD Billion) 48

TABLE 11 Global Needle-Free Paediatric Injection Market by Region, 2018-25 (USD Billion) 49

TABLE 12 Global Needle-Free Pain Management Market, by Region, 2018-25 (USD Billion) 50

TABLE 13 Specification of Needle-Free Devices By Injection Methods 52

TABLE 14 Global Needle-Free Powdered Injection Market by Region, 2018-25 (USD Billion) 53

TABLE 15 Examples of Drugs Administered via Liquid Jet Injector 53

TABLE 16 Global Needle-Free Liquid Injection Market by Region, 2018-25 (USD Billion) 54

TABLE 17 Global Needle-Free Depot or Projectile Injection Market by Region, 2018-25 (USD Billion) 54

TABLE 18 Global Needle-Free Spring Loaded Jet Injector Market by Region, 2018-25 (USD Billion) 56

TABLE 19 Global Needle-Free Gas Powered Jet Injector Market by Region, 2018-25 (USD Billion) 57

TABLE 20 Global Needle-Free Battery Powered Jet Injector Market by Region, 2018-25 (USD Billion) 58

TABLE 21 North America Needle Free Drug Delivery Device by Product 2018-25 (USD Billion) 62

TABLE 22 North America Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 62

TABLE 23 North America Needle-Free Drug Delivery Device by Application,2018-2025 (USD Billion) 63

TABLE 24 North America Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 63

TABLE 25 North America Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (USD Billion) 64

TABLE 26 Europe Needle-Free Drug Delivery Device by Product, 2018-25 (USD Billion) 68

TABLE 27 Europe Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 68

TABLE 28 Europe Needle-Free Drug Delivery Device by Application,2018-2025 (USD Billion) 69

TABLE 29 Europe Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 69

TABLE 30 Europe Needle-Free Drug Delivery Device, by Source of Power, 2018-25 (USD Billion) 70

TABLE 31 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in Asia-Pacific 71

TABLE 32 Asia Pacific Needle-Free Drug Delivery Device by Product, 2018-25 (USD Billion) 74

TABLE 33 Asia Pacific Needle-Free Drug Delivery Device by Technology, 2018-25 (USD Billion) 74

TABLE 34 Asia Pacific Needle-Free Drug Delivery Device by Application, 2018-2025 (USD Billion) 75

TABLE 35 Asia Pacific Needle-Free Drug Delivery Device by Injection Method, 2018-25 (USD Billion) 75

TABLE 36 Asia Pacific Needle-Free Drug Delivery Device by Source of Power, 2018-25 (USD Billion) 76

TABLE 37 Mortality from CVD, Cancer, Diabetes or CRD between 30 and 70 Years (%) in RoW 77

TABLE 38 RoW Needle-Free Drug Delivery Device Market by Product, 2018-25 (USD Billion) 78

TABLE 39 RoW Needle-Free Drug Delivery Device Market by Technology, 2018-25 (USD Billion) 78

TABLE 40 RoW Needle-Free Drug Delivery Device Market by Application,2018-2025 (USD Billion) 79

TABLE 41 RoW Needle-Free Drug Delivery Device Market by Injection Method, 2018-25 (USD Billion) 79

TABLE 42 RoW Needle-Free Drug Delivery Device Market by Source of Power, 2018-25 (USD Billion) 80

TABLE 43 Antares Pharma Inc. Key Facts 85

TABLE 44 Product segmentation of Antares Pharma Inc. 86

TABLE 45 Antares Pharma, Inc. Growth Strategy 86

TABLE 46 Antares Pharma Inc. Financials US USD Million 87

TABLE 47 Consort Medical Key Facts 90

TABLE 48 Product segmentation of Consort Medical 91

TABLE 49 Consort Medical Growth Strategy 91

TABLE 50 Consort Medical Financials, USD Million 92

TABLE 51 Crossject Societe Key Facts 94

TABLE 52 Product segmentation of Crossject Societe Anonyme 94

TABLE 53 Crossject Societe Anonyme Growth Strategy 95

TABLE 54 Crossject Societe Anonyme Financials, USD Million 95

TABLE 55 Inovio Pharmaceutical Key Facts 97

TABLE 56 Product segmentation of Inovio Pharmaceuticals 98

TABLE 57 Inovio Pharmaceuticals Growth Strategy 99

TABLE 58 Inovio Pharmaceuticals Financials, USD Million 100

TABLE 59 Injex Pharma Key Facts 102

TABLE 60 Product segmentation of Injex Pharma 102

TABLE 61 Injex Pharma Growth Strategy 103

TABLE 62 Medical International Technology Key Facts 104

TABLE 63 Product segmentation of Medical International Technology 105

TABLE 64 Medical International Technology Growth Strategy 105

TABLE 65 Medical International Technology Financials, USD Million 106

TABLE 66 Zosano Pharma Key Facts 107

TABLE 67 Product segmentation of Zosano Pharma 108

TABLE 68 Zosano Pharma Growth Strategy 108

TABLE 69 Zosano Pharma Financials, USD Million 109

TABLE 70 Valeritas Key Facts 111

TABLE 71 Product segmentation of Valeritas 112

TABLE 72 Valeritas Growth Strategy 112

TABLE 73 3M Key Facts 114

TABLE 74 Product segmentation of 3M 115

TABLE 75 3M Growth Strategy 115

TABLE 76 3M Financials, USD Million 116

TABLE 77 PharmaJet Key Facts 118

TABLE 78 Product segmentation of PharmaJet 118

TABLE 79 Pharmajet Growth Strategy 11

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Antares Pharma, Inc., Consort Medical, Crossject Societe Anonyme, Crossject Societe Anonyme, Injex Pharma, Medical International Technology, Zosano Pharma, Valeritas, 3M, PharmaJet